Loscocco, Giuseppe G.
Vannucchi, Alessandro M. https://orcid.org/0000-0001-5755-0730
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (21267)
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN-2017WXR7ZT)
Article History
Received: 6 March 2022
Revised: 6 March 2022
Accepted: 15 March 2022
First Online: 29 March 2022
Declarations
:
: AMV has personal fees as an advisory board and speaker fee from AOP Orphan Pharmaceuticals, Incyte, BMS, and Novartis, outside the submitted work. GGL has no conflict of interest to disclose.